
© 2024 wallstreetONLINE
Realtime | Geld | Brief | Zeit |
---|---|---|---|
132,06 | 132,46 | 05.07. | |
132,60 | 132,64 | 04.07. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short | ||
Do | FDA warns on issue with J&J Abiomed pump controllers related to 3 deaths | ||
Do | FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds | ||
Mi | Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth? | ||
Di | Johnson & Johnson's Drug Discount Plan Gets Thrown Out In Court |